Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Sven R. Olson; Bethany T. Samuelson-Bannow

doi:10.1056/NEJMc1902336

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Sven R. Olson, Bethany T. Samuelson-Bannow

Knight Cancer Institute

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	e32
Journal	The New England journal of medicine
Volume	380
Issue number	18
DOIs	https://doi.org/10.1056/NEJMc1902336
State	Published - May 2 2019

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc1902336

Cite this

@article{9a47e6e4d76740488b3b7a2915b19bff,

title = "Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura",

author = "Olson, {Sven R.} and Samuelson-Bannow, {Bethany T.}",

year = "2019",

month = may,

day = "2",

doi = "10.1056/NEJMc1902336",

language = "English (US)",

volume = "380",

pages = "e32",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "18",

}

TY - JOUR

T1 - Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

AU - Olson, Sven R.

AU - Samuelson-Bannow, Bethany T.

PY - 2019/5/2

Y1 - 2019/5/2

UR - http://www.scopus.com/inward/record.url?scp=85065511957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065511957&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1902336

DO - 10.1056/NEJMc1902336

M3 - Letter

C2 - 31042846

AN - SCOPUS:85065511957

SN - 0028-4793

VL - 380

SP - e32

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 18

ER -

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this